{"AllianceGenome": "3804", "HGNC": "3804", "MIM": "611539", "_id": "27022", "_version": 1, "accession": {"genomic": ["AF197560.1", "AL049636.22", "CH471059.2", "CP068277.2", "NC_000001.11", "NC_060925.1", "NG_012220.1"], "protein": ["AAF05844.1", "AAK13574.1", "EAX06575.1", "NP_036315.1", "Q9UJU5.1"], "rna": ["AF086235.1", "L12142.1", "NM_012183.3"], "translation": [{"protein": "AAK13574.1", "rna": "L12142.1"}, {"protein": "NP_036315.1", "rna": "NM_012183.3"}]}, "alias": ["AIS1", "Genesis", "HFH2", "VAMAS2"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "disputed", "classification_date": "2022-12-15T17:00:00.000Z", "disease_label": "aniridia", "gcep": "Glaucoma and Neuro-Ophthalmology Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0019172", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d4b3b44d-26d8-4519-9d0d-2259022e79c6-2022-12-15T170000.000Z", "sop": "SOP9"}}, "ensembl": {"gene": "ENSG00000187140", "protein": "ENSP00000360157", "transcript": "ENST00000371116", "translation": [{"protein": "ENSP00000360157", "rna": "ENST00000371116"}], "type_of_gene": "protein_coding"}, "entrezgene": "27022", "exons": [{"cdsend": 63324495, "cdsstart": 63323058, "chr": "1", "position": [[63322566, 63325128]], "strand": 1, "transcript": "NM_012183", "txend": 63325128, "txstart": 63322566}], "exons_hg19": [{"cdsend": 63790166, "cdsstart": 63788729, "chr": "1", "position": [[63788237, 63790799]], "strand": 1, "transcript": "NM_012183", "txend": 63790799, "txstart": 63788237}], "generif": [{"pubmed": 16098053, "text": "candidate for vitilago susceptibility and autosomal dominant with promoter variation"}, {"pubmed": 19034670, "text": "HIV-1 induces OTK18 expression through a YIN-YANG-1 mediated manner in human macrophages, although its gene expression is suppressed by FoxD3 upregulation"}, {"pubmed": 20332228, "text": "Studies show FOXD3 is suppressed by B-RAF, uncover a novel role and mechanism for FOXD3 as a negative cell cycle regulator, and have implications for the repression of melanocytic lineage cells."}, {"pubmed": 21478267, "text": "FOXD3 regulates migration properties and Rnd3 expression in melanoma cells"}, {"pubmed": 22815627, "text": "Six nonsynonymous FOXD3 variants were identified in human ocular disease."}, {"pubmed": 22887036, "text": "A balance of FOXD3 activity is required to maintain pluripotency and paraxial mesoderm fates."}, {"pubmed": 23058321, "text": "Methylation profile analyses identified the promoter of FOXD3 as the only genomic region with increased methylation in mice and humans during progression of Helicobacter pylori-associated gastric tumors."}, {"pubmed": 23543055, "text": "upregulation of ERBB3 is involved in melanoma adapting to RAF/MEK inhibitors through FOXD3"}, {"pubmed": 23858437, "text": "Foxd3 is both sufficient and necessary for regulating the balance between melanocyte and Schwann cell development. In addition, Foxd3 is also sufficient to regulate the switch between neuronal and glial fates in sensory ganglia."}, {"pubmed": 24269992, "text": "Results indicate that FOXD3 exhibits tumor suppressive activity that affects the growth, aggressiveness and angiogenesis of NB through transcriptional regulation of NDRG1."}, {"pubmed": 24551288, "text": "Results suggest an inverse relationship between FoxD3 expression and tumor metastasis in invasive ductal carcinomas of the breast."}, {"pubmed": 24632201, "text": "Our results indicate FOXD3 exhibits tumor suppressive activity and may be useful for breast therapy."}, {"pubmed": 24970808, "text": "Findings indicate that miR-137 is a valuable biomarker for hepatocellular carcinoma (HCC) prognosis and the forkhead box D3 (FoxD3)/miR-137/AKT2 regulatory network plays an important role in HCC progression."}, {"pubmed": 25061102, "text": "FOXD3 and TWIST1 define distinct subgroups of cells within a heterogeneous tumor."}, {"pubmed": 25894280, "text": "Results showed that silencing FoxD3 in lung cancer cell lines stimulated cell growth and inhibited cell apoptosis."}, {"pubmed": 26011451, "text": "FOXD3 might serve as an independent prognostic biomarker and a potential therapeutic target for high-grade gliomas, which warrant further investigation."}, {"pubmed": 26112097, "text": "Down-regulation of FOXD3 is associated with metastasis in hepatocellular carcinoma."}, {"pubmed": 26205821, "text": "Data show that transcription factors PAX3 and FOXD3-mediated melanoma cell migration is dependent on promoting the expression of chemokine receptor CXCR4."}, {"pubmed": 26252164, "text": "FOXD3 is sufficient but not necessary to drive PAX3 expression in melanoma cells."}, {"pubmed": 26267147, "text": "In addition to a possible association of rs78645479 in FoxD3 with vitiligo, our data on the association of this FoxD3 variant with thyroid autoantibodies suggest a potential involvement of FoxD3 in thyroid immunoregulation."}, {"pubmed": 26341266, "text": "FOXD3 overexpression significantly inhibits cell growth and results in G1 cell cycle arrest in NSCLC A549 and H1299 cells."}, {"pubmed": 26898989, "text": "The present study finds that the aspirin-FOXD3-OLA1P2-STAT3 axis exhibits exciting anticancer effects and provides new insights into the chemopreventive mechanisms underlying aspirin use"}, {"pubmed": 27027443, "text": "FOXO4 and FOXD3 were shown independently predictive of overall survival in gastric cancer"}, {"pubmed": 27811858, "text": "FOXD3/miR-214/MED19 axis is important for the regulation of growth, invasion and metastasis of colorectal cancer"}, {"pubmed": 27926503, "text": "Results show that FOXD3 expression was reduced in colon cancer cells. Its knockdown dramatically increased the proliferation of tumor cells, enhanced cell invasiveness and inhibited cell apoptosis. The study indicates that FOXD3 may play a protective role in human colon formation by regulating EGFR/Ras/Raf/MEK/ERK signal pathway."}, {"pubmed": 28349825, "text": "total of 1799 differentially methylated regions were identified including SLC6A3, Rab40C, ZNF584, and FOXD3 whose significant methylation differences were confirmed in breast cancer patients through quantitative real-time polymerase chain reaction.Methylation of those aforementioned genes in white blood cells of our young patients may highlight their potential as early epimarkers"}, {"pubmed": 28430585, "text": "FOXD3 knockdown resulted in enhanced ATC proliferation, invasion and migration and diminished cellular apoptosis. Further, we showed that FOXD3 regulated expression of E-cadherin by modulating MAPK/EKR signaling pathway that promotes EMT and metastasis during thyroid carcinogenesis."}, {"pubmed": 28851816, "text": "On the basis of these data, FOXD3 is a potent repressor of DCLK1-S expression in normal cells; loss of FOXD3 in hCCCs/hCRCs allows upregulation of DCLK1-S, imparting a potent invasive potential to the cells"}, {"pubmed": 30076902, "text": "FOXD3 acts as a repressor of the mitochondrial S-adenosylmethionine carrier (SLC25A26) gene expression in cancer cells."}, {"pubmed": 30350469, "text": "Tuning Forkhead Box D3 overexpression to promote specific osteogenic differentiation of human embryonic stem cells while reducing pluripotency in a three-dimensional culture system."}, {"pubmed": 30596382, "text": "Serum FOXD3 expression was weakly expressed in NSCLC patients compared to the controls at mRNA and protein levels (P<0.001) and low FOXD3 expression was positively correlated with TNM stage, lymph node metastasis, and differentiation."}, {"pubmed": 30703266, "text": "we found that FOXD3 represses WDR5, which regulates TIC-related signaling pathway. Moreover, WDR5 were positively correlated with the TIC abundance and tumor progression. Besides, patients with high expression of WDR5 presented a poorer overall survival. FOXD3 may suppress TIC accumulation by repressing the expression of WDR5 in lung cancer"}, {"pubmed": 31257522, "text": "the present results demonstrated that miR4255p promoted hepatocellular carcinoma (HCC) cell proliferation, migration, and invasion by suppressing FOXD3 expression, potentially providing a novel target for the treatment of HCC."}, {"pubmed": 31415841, "text": "The FOXD3 regulates the balance of human ESCs between pluripotency and meso-endoderm fates, which adds to our understanding of the role of FOXD3 in humans."}, {"pubmed": 31784734, "text": "FOXD3, frequently methylated in colorectal cancer, acts as a tumor suppressor and induces tumor cell apoptosis under ER stress via p53."}, {"pubmed": 31940493, "text": "FOXD3 Regulates VISTA Expression in Melanoma."}, {"pubmed": 32191537, "text": "LncRNA FOXD3-AS1 Mediates AKT Pathway to Promote Growth and Invasion in Hepatocellular Carcinoma Through Regulating RICTOR."}, {"pubmed": 32196603, "text": "Highly expressed lncRNA FOXD3-AS1 promotes non-small cell lung cancer progression via regulating miR-127-3p/mediator complex subunit 28 axis."}, {"pubmed": 32459973, "text": "FOXD3 inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma through regulation of the PI3K-Akt pathway."}, {"pubmed": 33204001, "text": "Long non-coding RNA FOXD3-AS1 silencing exerts tumor suppressive effects in nasopharyngeal carcinoma by downregulating FOXD3 expression via microRNA-185-3p upregulation."}, {"pubmed": 34551139, "text": "FOXD3 suppresses epithelial-mesenchymal transition through direct transcriptional promotion of SMAD7 in esophageal squamous cell carcinoma."}, {"pubmed": 35178865, "text": "FOXD3 and GAB2 as a pair of rivals antagonistically control hepatocellular carcinogenesis."}, {"pubmed": 36627652, "text": "FOXD3 confers chemo-sensitivity in ovarian cancer through a miR-335/DAAM1/myosin II axis-dependent mechanism."}, {"pubmed": 37151068, "text": "FOXD3 Suppresses the Proliferation of CRC Bone Metastatic Cells via the Ras/Raf/MEK/ERK Signaling Pathway."}], "genomic_pos": {"chr": "1", "end": 63325128, "ensemblgene": "ENSG00000187140", "start": 63322567, "strand": 1}, "genomic_pos_hg19": {"chr": "1", "end": 63790797, "start": 63788730, "strand": 1}, "go": {"BP": [{"evidence": "IDA", "gocategory": "BP", "id": "GO:0000122", "pubmed": 22306510, "qualifier": "involved_in", "term": "negative regulation of transcription by RNA polymerase II"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0000122", "qualifier": "involved_in", "term": "negative regulation of transcription by RNA polymerase II"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0001701", "qualifier": "involved_in", "term": "in utero embryonic development"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006357", "qualifier": "involved_in", "term": "regulation of transcription by RNA polymerase II"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0009653", "qualifier": "involved_in", "term": "anatomical structure morphogenesis"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0030154", "qualifier": "involved_in", "term": "cell differentiation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045944", "pubmed": 11891324, "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0000785", "pubmed": 22306510, "qualifier": "part_of", "term": "chromatin"}, {"evidence": "ISA", "gocategory": "CC", "id": "GO:0000785", "qualifier": "part_of", "term": "chromatin"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}], "MF": [{"category": "MF", "evidence": "IDA", "id": "GO:0000977", "pubmed": 22306510, "qualifier": "enables", "term": "RNA polymerase II transcription regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0000978", "qualifier": "enables", "term": "RNA polymerase II cis-regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0000981", "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "ISA", "id": "GO:0000981", "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "IDA", "id": "GO:0001227", "pubmed": 22306510, "qualifier": "enables", "term": "DNA-binding transcription repressor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "ISS", "id": "GO:0003700", "qualifier": "enables", "term": "DNA-binding transcription factor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 11891324, "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:1990837", "pubmed": 28473536, "qualifier": "enables", "term": "sequence-specific double-stranded DNA binding"}]}, "homologene": {"genes": [[7955, 30548], [8364, 496851], [9544, 696085], [9598, 456905], [9606, 27022], [9615, 489558], [9913, 532383], [10090, 15221], [10116, 29203]], "id": 49239}, "interpro": [{"desc": "Fork head domain", "id": "IPR001766", "short_desc": "Fork_head_dom"}, {"desc": "Fork head domain conserved site1", "id": "IPR018122", "short_desc": "TF_fork_head_CS_1"}, {"desc": "Fork head domain conserved site 2", "id": "IPR030456", "short_desc": "TF_fork_head_CS_2"}, {"desc": "Winged helix-like DNA-binding domain superfamily", "id": "IPR036388", "short_desc": "WH-like_DNA-bd_sf"}, {"desc": "Winged helix DNA-binding domain superfamily", "id": "IPR036390", "short_desc": "WH_DNA-bd_sf"}, {"desc": "Forkhead box protein D3, forkhead domain", "id": "IPR047392", "short_desc": "FH_FOXD3"}], "ipi": "IPI00007164", "map_location": "1p31.3", "name": "forkhead box D3", "other_names": ["HNF3/FH transcription factor genesis", "autoimmune susceptibility 1", "forkhead box protein D3"], "pantherdb": {"HGNC": "3804", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1347473", "ortholog_type": "LDO", "panther_family": "PTHR11829", "taxid": 10090, "uniprot_kb": "Q61060"}, {"Gene": "FOXD3", "ortholog_type": "LDO", "panther_family": "PTHR11829", "taxid": 9031, "uniprot_kb": "P79772"}, {"ZFIN": "ZDB-GENE-980526-143", "ortholog_type": "LDO", "panther_family": "PTHR11829", "taxid": 7955, "uniprot_kb": "F1R5S7"}, {"SGD": "S000001393", "ortholog_type": "O", "panther_family": "PTHR11829", "taxid": 4932, "uniprot_kb": "P40466"}, {"SGD": "S000000661", "ortholog_type": "O", "panther_family": "PTHR11829", "taxid": 4932, "uniprot_kb": "P25364"}, {"PomBase": "SPBC4C3.12", "ortholog_type": "O", "panther_family": "PTHR11829", "taxid": 4896, "uniprot_kb": "O43058"}, {"PomBase": "SPBC32H8.11", "ortholog_type": "O", "panther_family": "PTHR11829", "taxid": 4896, "uniprot_kb": "O13606"}], "uniprot_kb": "Q9UJU5"}, "pathway": {"reactome": [{"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-2892247", "name": "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"}, {"id": "R-HSA-452723", "name": "Transcriptional regulation of pluripotent stem cells"}, {"id": "R-HSA-9730414", "name": "MITF-M-regulated melanocyte development"}, {"id": "R-HSA-9730414", "name": "MITF-M-regulated melanocyte development"}, {"id": "R-HSA-9856649", "name": "Transcriptional and post-translational regulation of MITF-M expression and activity"}, {"id": "R-HSA-9856649", "name": "Transcriptional and post-translational regulation of MITF-M expression and activity"}], "wikipathways": [{"id": "WP2064", "name": "Neural Crest Differentiation"}, {"id": "WP399", "name": "Wnt signaling pathway and pluripotency"}]}, "pfam": "PF00250", "pharmgkb": "PA28221", "pharos": {"target_id": 976, "tdl": "Tbio"}, "prosite": "PS50039", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF170421", "relationship": "is"}, {"id": "GNF181327", "relationship": "is"}, {"id": "GNF192233", "relationship": "is"}, {"id": "GNF203139", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF095925", "relationship": "is"}, {"id": "GNF135581", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000001.11", "NC_060925.1", "NG_012220.1"], "protein": "NP_036315.1", "rna": "NM_012183.3", "translation": {"protein": "NP_036315.1", "rna": "NM_012183.3"}}, "reporter": {"HG-U133_Plus_2": ["208500_x_at", "241609_at", "241612_at"], "HTA-2_0": ["TC01000716.hg.1", "TC01004446.hg.1", "TC01004447.hg.1"], "HuEx-1_0": "2339658", "HuGene-1_1": "7901913", "HuGene-2_1": "16665507"}, "retired": 373071, "summary": "This gene belongs to the forkhead family of transcription factors which is characterized by a distinct forkhead domain. Mutations in this gene cause autoimmune susceptibility 1. [provided by RefSeq, Nov 2008].", "symbol": "FOXD3", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1414672"}, "unigene": "Hs.546573", "uniprot": {"Swiss-Prot": "Q9UJU5"}, "wikipedia": {"url_stub": "FOXD3"}}